Depression and anxiety are some of the most common comorbidities arising in patients with
Parkinson's disease. However, their timely recognition and diagnosis are often hindered by …

Background: Increased gut permeability (leaky gut) and alterations in gut microbiota are now
widely accepted as relevant to the etiology, course and treatment of many neuropsychiatric …

The biological underpinnings to the etiology and course of neurodegeneration in
Parkinson's disease are an area of extensive research that has yet to produce an early …

The prevalence of non-motor symptoms (NMS) in Parkinson's Disease (PD) has varied
between studies. Their interrelation isn't totally understood. Also, the relative importance of …

Abstract The occurrence of Functional Neurological Disorder (FND) and Somatic Symptom
Disorder (SSD) in PD was not commonly accepted until recently, despite some evidence that …

Background: Mutations in the human α-synuclein gene lead to early-onset Parkinson's
disease (PD); however, phenotypes of α-synuclein mutant mice vary depending upon the …

Although psychiatric comorbidity in Parkinson's Disease (PD) has often been studied, the
individual psychiatric symptoms have rarely been evaluated from a clinimetric point of view …

The current systematic review study is aimed at critically analyzing from a clinimetric
viewpoint the clinical consequence of somatization in Parkinson's Disease (PD). By focusing …

Background: Mood symptoms negatively affect quality of life of Parkinson's disease (PD);
however little is known about the impact of behavioral disorders such as impulse control …

Functional movement disorder (FMD) is a common manifestation of functional neurological
disorder. FMD can occur alongside other neurological conditions, but especially in patients …